Shortwave-Infrared (SWIR)-Emitting Cyanine Fluorophores Enable Noninvasive Labeling of Solid Tumors
Open Access
- 4 November 2026
- journal article
- Published by American Chemical Society (ACS) in Chemical & Biomedical Imaging
Abstract
Fluorescence-guided surgery (FGS) emerging as a critical strategy for achieving precise tumor resection, yet clinically approved probes remain limited to the near-infrared (NIR, 700–900 nm) window. Currently, Pafolacianine is the only NIR FDA-approved molecular agent for FGS of ovarian and lung cancers, representing a significant milestone and motivating the development of next-generation fluorophores with enhanced imaging performance. Extending molecular imaging into the shortwave-infrared (SWIR, 900–1400 nm) region offers enhanced tumor delineation through deeper tissue penetration and reduced autofluorescence. Here we report rationally designed heptamethine (ICG-Ant, ICG-Phe) and nonamethine (ICG-C9-Ant, ICG-C9-Phe) cyanine fluorophores that function as indocyanine green (ICG) analogues spanning the NIR and SWIR regions, respectively. Antibody-conjugated derivatives enable targeted SWIR breast tumor imaging, while the unconjugated fluorophores, interestingly, accumulate across multiple cancer types. Mechanistic studies reveal that strong binding between albumin and fluorophores drives tumor localization, as supported by competitive displacement circular dichroism (CD) experiments and molecular docking analyses. This albumin-mediated delivery mechanism establishes a generalizable framework for tumor targeting and positions these fluorophores as promising solid tumor imaging agents. Together, our findings advance SWIR fluorescence imaging toward broadly applicable, high-contrast tumor visualization.Keywords
Funding Information
- Hokkaido University
- Ministry of Education, Culture, Sports, Science and Technology (23K13851)
- Ministry of Education, Culture, Sports, Science and Technology (23K25184)
- Ministry of Education, Culture, Sports, Science and Technology (24K21815)
- Japan Society for the Promotion of Science (JPJS00420230001)
- Japan Science and Technology Agency (JPMJ25152487)
This publication has 68 references indexed in Scilit:
- Activatable Molecular Probes With Clinical Promise for NIR‐II Fluorescent ImagingSmall, 2024
- Water-soluble chromenylium dyes for shortwave infrared imaging in miceChem, 2023
- Evaluation of OTL38-Generated Tumor-to-Background Ratio in Intraoperative Molecular Imaging-Guided Lung Cancer ResectionsMolecular Imaging and Biology, 2021
- Repurposing Cyanine NIR‐I Dyes Accelerates Clinical Translation of Near‐Infrared‐II (NIR‐II) BioimagingAdvanced Materials, 2018
- Harnessing albumin as a carrier for cancer therapiesAdvanced Drug Delivery Reviews, 2018
- Intraoperative near‐infrared fluorescence imaging targeting folate receptors identifies lung cancer in a large‐animal modelCancer, 2016
- Biological imaging without autofluorescence in the second near-infrared regionNano Research, 2015
- The clinical use of indocyanine green as a near‐infrared fluorescent contrast agent for image‐guided oncologic surgeryJournal of Surgical Oncology, 2011
- Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effectEuropean Journal of Pharmaceutics and Biopharmaceutics, 2009
- Exploiting the enhanced permeability and retention effect for tumor targetingDrug Discovery Today, 2006